IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11285226 B1

PDFFull Text
Date of Patent:
Mar. 29, 2022

Filed:

Nov. 07, 2019

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

Applicants:

Daegu-gyeongbuk Medical Innovation Foundation, Daegu, KR;

Kyungpook National University Hospital, Daegu, KR;

Kyungpook National University Industry-academic Cooperation Foundation, Daegu, KR;

Inventors:

Sung Yeoun Hwang, Incheon, KR;

Sung Jin Cho, Daegu, KR;

Jina Kim, Daegu, KR;

Jungwook Chin, Daegu, KR;

Hayoung Hwang, Daegu, KR;

In-Kyu Lee, Daegu, KR;

Yong-Hyun Jeon, Daegu, KR;

Jaetae Lee, Daegu, KR;

Jae-Han Jeon, Daegu, KR;

Sang Wook Kim, Seoul, KR;

Assignees:

Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, KR;

KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL, Daegu, KR;

Kyungpook National University Industry-Academic Cooperation Foundation, Daegu, KR;

Attorney:

McCoy Russell LLP

Primary Examiner:

James W Rogers

Int. Cl.
CPC ...
A61K 51/02 (2006.01); A61K 31/396 (2006.01); A61K 31/397 (2006.01); A61K 31/496 (2006.01); C07D 265/28 (2006.01); C07D 241/04 (2006.01); C07D 203/08 (2006.01); A61K 31/535 (2006.01); A61P 35/00 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 31/4192 (2006.01); A61K 31/445 (2006.01); A61K 31/454 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 31/695 (2006.01);
U.S. Cl.
CPC ...
A61K 51/025 (2013.01); A61K 31/396 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/403 (2013.01); A61K 31/404 (2013.01); A61K 31/407 (2013.01); A61K 31/4192 (2013.01); A61K 31/445 (2013.01); A61K 31/454 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/535 (2013.01); A61K 31/5375 (2013.01); A61K 31/695 (2013.01); A61P 35/00 (2018.01); C07D 203/08 (2013.01); C07D 241/04 (2013.01); C07D 265/28 (2013.01);
Abstract

The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERRγ) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.

Find Patent Forward Citations

Loading…